Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 24;379(2):13.
doi: 10.1007/s41061-020-00314-6.

Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines

Affiliations
Review

Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines

Mallu Lavanya et al. Top Curr Chem (Cham). .

Abstract

The burgeoning interest in synthesis and biological applications of 1,6-naphthyridines reflects the importance of 1,6-naphthyridines in the synthetic as well as medicinal chemistry fields. Specially, 1,6-naphthyridines are pharmacologically active, with variety of applications such as anticancer, anti-human immunodeficiency virus (HIV), anti-microbial, analgesic, anti-inflammatory and anti-oxidant activities. Although collective recent synthetic developments have paved a path to a wide range of functionalized 1,6-naphthyridines, a complete correlation of synthesis with biological activity remains elusive. The current review focuses on recent synthetic developments from the last decade and a thorough study of the anticancer activity of 1,6-naphthyridines on different cancer cell lines. Anticancer activity has been correlated to 1,6-naphthyridines using the literature on the structure-activity relationship (SAR) along with molecular modeling studies. Exceptionally, at the end of this review, the utility of 1,6-naphthyridines displaying activities other than anticancer has also been included as a glimmering extension.

Keywords: 1,6-Naphthyridines; Anticancer activity; Cancer cell lines; Mechanism of action; Molecular modeling studies; Structural–activity relationship; Synthetic approaches.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kumar D, Jain SK (2016) Curr Med Chem 23:4338–4394 - PubMed
    1. Litvinov VP (2006) Adv Heterocycl Chem 91:189–300
    1. Garcia-Valverde M, Torroba T (2008) Molecules 10:318–320
    1. Zheng L, Bin Y, Wang Y, Hua R (2016) J Org Chem 81:8911–8919 - PubMed
    1. Bracher F, Mink K (1995) Liebigs Ann 20:645–647

MeSH terms

LinkOut - more resources